S&P 500   3,335.39 (-1.12%)
DOW   28,960.37 (-0.89%)
QQQ   230.15 (-1.97%)
AAPL   313.09 (-2.25%)
FB   209.66 (-2.29%)
MSFT   178.40 (-3.26%)
GOOGL   1,492.83 (-1.59%)
AMZN   2,101.63 (-2.39%)
CGC   21.97 (-1.52%)
NVDA   293.61 (-4.89%)
BABA   212.70 (-2.45%)
MU   56.58 (-4.10%)
GE   12.29 (-1.92%)
TSLA   886.23 (-1.47%)
AMD   53.35 (-6.84%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.91 (-1.49%)
NFLX   379.83 (-1.60%)
BAC   34.20 (-1.87%)
DIS   139.08 (-0.92%)
S&P 500   3,335.39 (-1.12%)
DOW   28,960.37 (-0.89%)
QQQ   230.15 (-1.97%)
AAPL   313.09 (-2.25%)
FB   209.66 (-2.29%)
MSFT   178.40 (-3.26%)
GOOGL   1,492.83 (-1.59%)
AMZN   2,101.63 (-2.39%)
CGC   21.97 (-1.52%)
NVDA   293.61 (-4.89%)
BABA   212.70 (-2.45%)
MU   56.58 (-4.10%)
GE   12.29 (-1.92%)
TSLA   886.23 (-1.47%)
AMD   53.35 (-6.84%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.91 (-1.49%)
NFLX   379.83 (-1.60%)
BAC   34.20 (-1.87%)
DIS   139.08 (-0.92%)
S&P 500   3,335.39 (-1.12%)
DOW   28,960.37 (-0.89%)
QQQ   230.15 (-1.97%)
AAPL   313.09 (-2.25%)
FB   209.66 (-2.29%)
MSFT   178.40 (-3.26%)
GOOGL   1,492.83 (-1.59%)
AMZN   2,101.63 (-2.39%)
CGC   21.97 (-1.52%)
NVDA   293.61 (-4.89%)
BABA   212.70 (-2.45%)
MU   56.58 (-4.10%)
GE   12.29 (-1.92%)
TSLA   886.23 (-1.47%)
AMD   53.35 (-6.84%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.91 (-1.49%)
NFLX   379.83 (-1.60%)
BAC   34.20 (-1.87%)
DIS   139.08 (-0.92%)
S&P 500   3,335.39 (-1.12%)
DOW   28,960.37 (-0.89%)
QQQ   230.15 (-1.97%)
AAPL   313.09 (-2.25%)
FB   209.66 (-2.29%)
MSFT   178.40 (-3.26%)
GOOGL   1,492.83 (-1.59%)
AMZN   2,101.63 (-2.39%)
CGC   21.97 (-1.52%)
NVDA   293.61 (-4.89%)
BABA   212.70 (-2.45%)
MU   56.58 (-4.10%)
GE   12.29 (-1.92%)
TSLA   886.23 (-1.47%)
AMD   53.35 (-6.84%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.91 (-1.49%)
NFLX   379.83 (-1.60%)
BAC   34.20 (-1.87%)
DIS   139.08 (-0.92%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ADMA BiologicsSutro BiopharmaCASI PharmaceuticalsScholar RockTcr2 Therapeutics
SymbolNASDAQ:ADMANASDAQ:STRONASDAQ:CASINASDAQ:SRRKNASDAQ:TCRR
Price Information
Current Price$3.84$11.64$2.17$14.24$14.01
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$10.20$19.17$7.00$27.00$26.33
% Upside from Price Target165.63% upside64.66% upside222.58% upside89.61% upside87.96% upside
Trade Information
Market Cap$229.56 million$263.23 million$208.11 million$423.81 million$353.24 million
Beta2.621.121.190.34N/A
Average Volume1,735,27361,742242,25071,99466,603
Sales & Book Value
Annual Revenue$16.99 million$38.42 millionN/AN/AN/A
Price / Sales13.417.00N/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.43 per share($6.58) per share$1.15 per share$4.22 per shareN/A
Price / Book8.93-1.77N/AN/AN/A
Profitability
Net Income$-65,740,000.00$-35,320,000.00$-27,470,000.00$-49,330,000.00$-24,250,000.00
EPS($1.45)($6.13)($0.32)($3.15)($98.53)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-260.92%-84.03%N/AN/AN/A
Return on Equity (ROE)-203.21%N/A-38.08%-47.83%-40.15%
Return on Assets (ROA)-51.17%-21.60%-31.00%-29.49%-26.51%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.33%N/AN/A0.04%N/A
Current Ratio6.42%3.78%10.56%5.51%21.14%
Quick Ratio3.76%3.78%10.19%5.51%21.14%
Ownership Information
Institutional Ownership Percentage62.76%50.80%12.79%59.67%42.74%
Insider Ownership Percentage15.20%28.90%24.29%41.40%39.07%
Miscellaneous
Employees3141411246547
Shares Outstanding59.32 million23.09 million96.35 million29.68 million24.03 million
Next Earnings Date3/11/2020 (Estimated)4/6/2020 (Estimated)4/3/2020 (Estimated)3/16/2020 (Estimated)4/6/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel